Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 07, 2015 5:03 AM ET

Life Sciences Tools and Services

Company Overview of Absorption Systems, LP

Company Overview

Absorption Systems, LP operates as a preclinical contract research organization. The company assists pharmaceutical, biotechnology, and medical device companies in identifying and overcoming absorption, distribution, metabolism, excretion, and toxicity barriers in the development of drugs, biologics, and medical devices. It offers preclinical services comprising predesigned and customizable assays and studies, which include lead optimization, NDA-enabling and IND-enabling, and bioanalysis services. The company also provides preclinical formulation profiling and characterization of biologics focusing on polypeptides, recombinant proteins, monoclonal antibodies, protein conjugates, nucleic aci...

436 Creamery Way

Suite 600

Exton, PA 19341

United States

Founded in 1996

Phone:

610-280-7300

Fax:

610-280-9667

Key Executives for Absorption Systems, LP

Co-Founder, Chief Executive Officer and President
Co-Founder and Chief Scientific Officer
Chief Financial Officer
Chief Operating Officer
Vice President of Scientific and Corporate Communications
Compensation as of Fiscal Year 2015.

Absorption Systems, LP Key Developments

Absorption Systems Announces License Agreement with Pfizer Inc

Absorption Systems announced a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein). This proprietary human BCRP assay system is designed to enable the testing of new drug candidates for interactions with the BCRP protein, which is involved in drug clearance, blood-brain barrier penetration, resistance of tumors to anticancer drugs, and drug-drug interactions. As a result of BCRP interactions, compounds that show promising efficacy in vitro may be inaccessible to the organ of interest during clinical trials.

Similar Private Companies By Industry

Company Name Region
Provid Pharmaceuticals, Inc. United States
BASi Maryland, Inc. United States
Coferon, Inc. United States
MedStar Research Institute, Inc. United States
Institute for Biological Research & Development Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Absorption Systems, LP, please visit www.absorption.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.